This study was designed to compare the radiation dose in abdominal dual-energy (DE) and single-energy (SE) acquisitions obtained in clinical practice with a second-generation DE computed tomography (DECT) and to analyze the dose variation in comparison with an SE acquisition performed with a 64-row SECT (SECT).
A total of 130 patients divided into 2 groups underwent precontrast and portal abdominal 128-row CT examination. In group A, DE portal acquisition was performed using a detector configuration of 2 × 40 × 0.6 mm, tube A at 80 kVp and a reference value of 559 mAs, tube B at 140 kVp and a reference value of 216 mAs, pitch 0.6, and online dose modulation; group B underwent SE portal acquisition using a detector configuration of 64 × 0.6 mm, 120 kVp and a reference value of 180 mAs, pitch 0.75, and online dose modulation. Group C consisted of 32 subjects from group A previously studied with 64-row SECT using the following parameters: detector configuration 64 × 0.6 mm, 120 kVp and a reference value of 180 mAs, pitch 0.75, and online dose modulation. In each group, the portal phase dose-length product and radiation dose (mSv) were calculated and normalized for a typical abdominal acquisition of 40 cm.
After normalization to standard 40-cm acquisition, a dose-length product of 599.0 ± 133.5 mGy · cm (range, 367.5 ± 1231.2 mGy · cm) in group A, 525.9 ± 139.2 mGy · cm (range, 215.7–882.8 mGy · cm) in group B, and 515.9 ± 111.3 mGy · cm (range, 305.5–687.2 mGy · cm) in group C was calculated for portal phase acquisition.
A significant radiation dose increase (P < 0.05) was observed in group A (10.2 ± 2.3 mSv) compared with group B (8.9 ± 2.4) and group C (8.8 ± 1.9 mSv). No significant difference (P > 0.05) was reported between SE 64- and 128-row acquisitions. A significant positive correlation between radiation dose and body mass index was observed in each group (group A, r 2 = 0.59, P < 0.0001; group B, r 2 = 0.35, P < 0.0001; group C, r 2 = 0.20, P = 0.0098).
In clinical practice, abdominal DECT acquisition shows a significant but minimal radiation dose increase, on the order of 1 mSv, compared with 64- and 128-row SE acquisition. The slightly increased radiation dose can be justified if the additional information obtained using a spectral imaging approach directly impacts on patient management or reduce the overall radiation dose with the generation of virtual unenhanced images, which can replace the precontrast acquisition.
From the *Department of Radiological Sciences, Oncology and Pathology, University of Rome “Sapienza”–Polo Pontino, Latina, Italy; and †Department of Radiology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Received for publication October 22, 2012; accepted March 10, 2013.
Reprints: Carlo Nicola De Cecco, MD, Department of Radiological Sciences, Oncology and Pathology, University of Rome “Sapienza”–Polo Pontino, Via Franco Faggiana, 34. 04100 Latina, Italia (e-mail: email@example.com).
All authors have no conflict of interest to disclose relevant to this investigation.